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INTRODUCTION
The Strategic and Technical Advisory Group 
of Experts (STAGE) for Maternal, Newborn, 
Child, Adolescent Health and Nutrition 
(MNCAHN) which advises the Director- 
General of WHO, marked its first anniversary 
in April 2021 as it concluded its third virtual 
meeting. STAGE has 31 members from all 
WHO regions and includes the key discipline 
groups that focus on MNCAHN. STAGE is 
an independent advisory group that takes a 
critical look at initiatives and programmes at 
WHO related to MNCHAN. STAGE provides 
an opportunity to monitor progress, connect 
agendas and groups and is a space to facil-
itate synergies across WHO departments, as 
well as with other United Nations (UN) agen-
cies.
STAGE was created in response to the 
global review to improve child survival and 
health1 that highlighted the need for a global 
expert group to appraise evidence, provide 
advice on interventions and implementation 
strategies and improve alignment between 
global and national stakeholders. This review, 
along with the Global Strategy for Women’s, 
Children’s and Adolescents’ Health (2016–
2030)2 articulated the need to address the 
broader determinants of health, and to move 
beyond a focus on survival to thrive and trans-
form contributing to the Sustainable Devel-
opment Goals (SDG). STAGE, while advising 
and helping WHO, brings together compre-
hensive and connected perspectives and is 
committed to making recommendations that 
support countries and regions. As a global 
advisory body, the observations and recom-
mendations of STAGE will be relevant not 
only to WHO but to all partners, including 
other UN agencies and donors who can make 
guided investments.
STAGE was launched in the early months of 
the COVID-19 pandemic and this has shaped 
Summary box
 ► The Strategic and Technical Advisory Group of 
Experts (STAGE) for Maternal, Newborn, Child, 
Adolescent Health and Nutrition (MNCAHN) was es-
tablished by the Director- General of WHO in 2020.
 ► STAGE is an independent advisory group with 31 mem-
bers. The key role is to provide a critical review of initia-
tives and programmes at WHO related to MNCHAN, to 
monitor progress, connect agendas and groups and is 
a space to facilitate synergies across WHO departments, 
as well as with other United Nations agencies.
 ► STAGE was created in response to the global review to 
improve child survival and health that highlighted the 
need for a global expert group to appraise evidence, 
provide advice on interventions and implementation 
strategies and improve alignment between global and 
national stakeholders.
 ► STAGE’s recommendations have highlighted the critical 
importance of sustaining essential services, includ-
ing MNCAHN, the need to improve the translation of 
evidence- based guidelines into successful programmes 
at the country level and the need for evidence- based 
packages of interventions for maternal and child health 
along the life course.
 ► STAGE will continue to advise on priority areas to im-
prove MNCAHN outcomes to achieve the Sustainable 
Development Goals. STAGE’s work will continue to ad-
dresses universal health coverage, which been inter-
rupted by the pandemic, and with a clear emphasis on 
cross- sectoral approaches.
 ► In the next 2 years, STAGE will narrow its agenda to 
specific topics where WHO and the global MNCHAN 
community seek guidance. To support this transition, 
and ensure its future agenda is responsive to expressed 
needs, STAGE will global inputs and oversee a prioritisa-
tion process.
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much of the discussions. Throughout our meetings, we 
have recognised the incredible sacrifices being made 
by health workers around the world, often at consider-
able personal risk where personal protective equipment, 
vaccines and care are inadequate. Health workers are 
striving to deliver critical MNCAHN services despite 
considerable disruptions which threaten to unravel prog-
ress made over the past decade. STAGE recognises that 
no mother, newborn, child or adolescent is safe until 
they and the health workers who look after them are safe, 
including access to vaccines and other tools for infection 
prevention, as well as safe from violence, burn- out and 
poor health.
As well as three formal meetings to articulate recom-
mendations, STAGE also established working groups, 
that met frequently, to enable deeper engagement on 
specific areas of work. Meetings have actively engaged 
and co- opted people from WHO headquarters and 
regional offices and members of non- governmental 
organisations to explore diverse opinions, prior to final-
ising STAGE recommendations. In its first year, STAGE 
provided recommendations on some of the key strategic 
challenges WHO needs to tackle to improve MNCAHN 
outcomes including addressing COVID-19 disruptions. 
As it moves forward, STAGE will narrow its agenda to 
specific topics where WHO and the global MNCHAN 
community seek guidance. To support this transition, 
and ensure its future agenda is responsive to expressed 
needs, STAGE will seek global inputs and oversee a prior-
itisation process.
MNCAHN NEEDS IN A PANDEMIC
STAGE’s birth in the context of an unprecedented 
pandemic revealed the importance of sustaining essen-
tial services, including MNCAHN. STAGE recommended 
strengthening coordination in the measurement of 
disruption and mitigation efforts to reduce the impact 
of the pandemic on MNCAHN services.3 4 Facilitating 
a more effective response for mothers, newborns, chil-
dren and adolescents at times of shock or crisis situations 
requires real- time quality data at the country level and 
this has largely been absent. WHO has provided recent 
guidance on using routine data to analyse disruption and 
STAGE further emphasised the need for sustained invest-
ment and local ownership, for relevant, robust and reli-
able health information systems.4 5
Having a critical review of solutions and learning from 
countries during the pandemic will support resilience 
against inevitable future disruptions, including the resur-
gence of COVID-19 infections. STAGE recommended 
that WHO, with other partners, manage the efforts to 
optimise research, minimise duplication and advised 
on the collation and synthesis of the many studies to 
enhance global knowledge of critical interventions that 
better anticipate needs and maintain essential MNCAHN 
services during shocks.3 STAGE also highlighted that, 
without healthcare workers, there will be no recovery, no 
‘building back better’, and the pandemic will lead to a 
seismic gap in the health workforce.
EVIDENCE TO IMPACT
STAGE has made key recommendations to improve the 
translation of evidence- based guidelines into successful 
programmes at the country level, especially in difficult 
and resource- constrained environments.4 An example 
of this translation is to support the scale- up of Kangaroo 
Mother Care (KMC) especially with the release of the 
findings from the Immediate KMC trial.6 STAGE will 
oversee a working group with wide membership to 
develop a position paper and implementation strategy to 
guide the investment and scale- up of KMC within an inte-
grated maternal and newborn care services approach.3 
At a broader level, STAGE also recommended that WHO 
support the formation, or consolidation, of Regional and 
National Technical Advisory Groups to provide advice 
based on local epidemiological and equity concerns and 
monitor the progress of national MNCAHN goals.4
MATERNAL AND CHILD HEALTH REDESIGN: TAKING A LIFE-
COURSE APPROACH
The strategic shift from survive to thrive and transform 
in child and adolescent health,7 accompanied by a frame-
work8 for interventions at different stages of life, was 
presented by WHO and approved by STAGE. WHO, in 
collaboration with UNICEF, will develop evidence- based 
packages of interventions for maternal and child health 
along the life course and through platforms which they 
can be delivered, accompanied by indicators, programme 
guidance and tools to support implementation. STAGE 
will regularly review and steer these outputs.
STAGE supported WHO’s visionary work with UNESCO 
to make every school a Health Promoting School. This 
recognises the untapped potential of schools to promote 
health and well- being of children and adolescents, as a 
core consideration within the education process and a 
measure of performance of national education systems.9
CONCLUSION
In conclusion, STAGE is advising and supporting the 
Director- General of WHO on priority areas to improve 
MNCAHN outcomes to achieve the SDGs. STAGE’s work 
will continue to address universal health coverage, which 
has been interrupted by the pandemic, and we have a 
clear emphasis on cross- sectoral approaches. However, 
for STAGE recommendations to have broad and 
sustained impact requires the commitment of, not only 
WHO, but all stakeholders including other UN agencies, 
governments, non- governmental organisations and the 
private sector.
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